Skip to main content
SSO 2024 Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Recorded for On-Demand Viewing

  1. Home

  • Thursday, Mar 21st
    9:45am – 10:15am ET
    Melanoma SLN is Positive, Now What? Debate: Surveillance vs. Adjuvant Immune Checkpoint Blockade for Stage 3a/b Melanoma
    Location: SSO HUB: Immuno-Oncology Zone
    HUB Moderator: Michael D. Alvarado, MD (he/him/his) – UCSF Helen Diller Family Comprehensive Cancer Center
    Immuno-OncologyHUBnon-CME
  • Thursday, Mar 21st
    4:00pm – 4:30pm ET
    The Role of Neoadjuvant Immune Checkpoint Blockade for Infiltrating Breast Cancer and DCIS
    Location: SSO HUB: Immuno-Oncology Zone
    HUB Moderator: Farin Amersi, MD (she/her/hers) – Cedars-Sinai Medical Center
    Immuno-Oncologynon-CMEHUB
  • Friday, Mar 22nd
    11:30am – 12:00pm ET
    How should we use ctDNA to Treat Patients with Advanced Colon and Pancreatic Cancer?
    Location: SSO HUB: Immuno-Oncology Zone
    HUB Moderator: Simon Turcotte, MD, MSc (he/him/his) – Université de Montréal
    Immuno-Oncologynon-CMEHUB
  • Friday, Mar 22nd
    3:15pm – 3:45pm ET
    Promising Bispecific Antibodies and Adoptive Cell Therapies for GI/HPB Cancers
    Location: SSO HUB: Immuno-Oncology Zone
    HUB Moderator: Ajay V. Maker, MD – University of California, San Francisco
    Immuno-Oncologynon-CMEHUB
  • Friday, Mar 22nd
    4:00pm – 5:00pm ET
    Hot Topics - Practice Changing Studies in Immuno-Oncology
    Location: C101
    Moderator: Ajay V. Maker, MD – University of California, San Francisco
    Immuno-OncologyCME
  • Saturday, Mar 23rd
    12:30pm – 2:30pm ET
    Society for Immunotherapy of Cancer (SITC) Session
    Location: C105-106
    Immuno-Oncology